Skip to main content
Article
The Balm of Gilead: Is the Provision of Treatment to those Who Seroconvert in HIV Prevention Trials a Matter of Moral Obligation or Moral Negotiation?
Journal of Law, Medicine & Ethics (2006)
  • Charles Weijer, The University of Western Ontario
  • Guy J. Leblanc, Dalhousie University
Abstract

Must treatment be provided to subjects who acquire HIV during the course of a prevention study? An analysis of ethical foundation, regulation, and recent argumentation provides no basis for the obligation. We outline an alternative approach to the problem based on moral negotiation.

Keywords
  • Clinical Trials,
  • Compensation and Redress,
  • Developing Countries,
  • International Cooperation,
  • Moral Obligations
Publication Date
Winter 2006
Citation Information
Charles Weijer and Guy J. Leblanc. "The Balm of Gilead: Is the Provision of Treatment to those Who Seroconvert in HIV Prevention Trials a Matter of Moral Obligation or Moral Negotiation?" Journal of Law, Medicine & Ethics Vol. 34 Iss. 4 (2006)
Available at: http://works.bepress.com/charlesweijer/51/